Clinical trial

Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067

NCT02071810

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention BIA 9-1067 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-04-01

PhasePHASE1

Conditions

Parkinson's Disease (PD)unresolved

Interventions

BIA 9-1067DRUG

PlaceboDRUG

Sponsors & collaborators

Bial - Portela C S.A.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02071810 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.